PR Newswire
IRVINE, Calif., April 27, 2017
IRVINE, Calif., April 27, 2017 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical
care monitoring, is scheduled to present at the Deutsche Bank 42nd Annual Health Care Conference at The
InterContinental Hotel in Boston, MA on Wednesday, May 3,
2017.
Scott B. Ullem, chief financial officer, is scheduled to speak to conference attendees at
10:40 a.m. ET. A live webcast of the presentation will be available to all interested parties on
the Edwards Lifesciences investor relations website at http://ir.edwards.com/events.cfm. Following the presentation, an archived version of the webcast will be
available on the Edwards investor relations website in the News and Events section, and via the Edwards Lifesciences Investor
Relations App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused
medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help
patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working
to improve patient outcomes and enhance lives. For more information, visit www.Edwards.com and follow us on Twitter at @EdwardsLifesci.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-300442627.html
SOURCE Edwards Lifesciences Corporation